Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.4944
+0.1100 (28.62%)
At close: Jan 9, 2026, 4:00 PM EST
0.4991
+0.0047 (0.95%)
After-hours: Jan 9, 2026, 7:59 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
Rare Disease Therapies
12.43M